The short-circuit evidence on lipid-lowering drugs use in pregnancy

Atherosclerosis. 2023 Mar:368:12-13. doi: 10.1016/j.atherosclerosis.2023.01.023. Epub 2023 Jan 30.

Authors

Federica Fogacci¹, Claudio Borghi², Arrigo F G Cicero²

Affiliations

¹ Hypertension and Cardiovascular risk factors Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy. Electronic address: federicafogacci@gmail.com.
² Hypertension and Cardiovascular risk factors Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy; IRCCS AOU S. Orsola-Malpighi, Bologna, Italy.

PMID: 36754660
DOI: 10.1016/j.atherosclerosis.2023.01.023

No abstract available

Keywords: Cardiovascular risk factors; Epidemiological study; Lipids; Pregnancy.

Publication types

Editorial

MeSH terms

Cardiovascular Diseases*
Female
Humans
Hypolipidemic Agents*
Lipids
Pregnancy
Risk Factors

Substances

Hypolipidemic Agents
Lipids